Evidence-Based Look at Wegovy

Solid protocol. One suggestion: consider adding HRV tracking if you are not already. It has been the most objective and responsive metric for me during my Wegovy protocol. Changes in HRV preceded subjective improvements by about a week, which gave me early confidence the protocol was working.

Your point about consistency being more important than optimization really resonates. I wasted weeks early in my Wegovy journey tweaking doses and timing when I should have just picked a reasonable protocol and stuck with it. The best results came when I stopped overthinking and just stayed consistent.

This is a great discussion about Wegovy. I want to add that I found morning dosing on an empty stomach gave me noticeably better results than evening dosing. Tried both for 4 weeks each. The difference was subtle but consistent across my tracking metrics.

Appreciate the evidence hierarchy approach. Too much of the peptide community treats anecdotal reports as equivalent to RCT data. They are both useful but for different purposes. Anecdotes generate hypotheses, RCTs test them.

The sigmoidal dose-response with a clear minimum effective dose is useful practical info. For cost-conscious users this means finding the lowest effective dose saves money without sacrificing results. Have you identified where that inflection point is?

The preclinical-to-clinical translation being better than average is encouraging. So many peptides show amazing results in rats and then underwhelm in humans. If Wegovy is maintaining effect sizes across species that bodes well for the clinical data we have.

Combination protocols leveraging mechanistic synergies - can you elaborate on which complementary compounds you think pair well with Wegovy? I am particularly interested in whether stacking with anti-inflammatory peptides enhances outcomes.